AI Agentic Workflow for Aggregating and Triaging Patient Forum & Call Center Signals

This workflow automates the continuous monitoring of unstructured patient feedback from forums, social media, and call center transcripts—a high-volume, high-noise data source traditionally reviewed manually. It directly addresses the operational bottleneck of delayed signal detection, compressing the timeline from patient report to validated case. The commercial upside is clear: earlier intervention reduces patient risk, lowers potential liability, and improves compliance posture by surfacing signals missed by traditional spontaneous reporting channels.

Implementation requires orchestrating specialized agents using LangGraph for state management, integrated with existing telephony and social listening APIs. The architecture must include configurable priority scoring, MedDRA dictionary lookups via RAG, and explicit routing rules to legacy PV systems like Oracle Argus. Critical controls include an immutable audit log of all agent actions, a mandatory human-in-the-loop review gate for high-priority signals, and continuous model monitoring for drift in sentiment and entity extraction accuracy to maintain regulatory defensibility.

This orchestration layer automates the labor-intensive, manual monitoring of patient-generated content, a critical bottleneck in post-market safety. It eliminates the need for safety associates to manually scan forums and transcripts, directly reducing monitoring labor by 60-80%. The business value is earlier signal detection, lower risk of missed reports, and the operational leverage to scale surveillance without linearly adding headcount. Implementation requires integrating real-time API listeners, a stateful orchestrator like LangGraph, and MedDRA/WHO-DD coding services.

The architecture is built for production, not experimentation. Key controls include a human review gate for all high-priority signals before case creation, ensuring medical oversight. The system integrates with legacy safety databases (e.g., ARISg, Veeva Safety) and call center platforms via secure APIs. Exception handling routes ambiguous signals for manual coding, and the entire workflow is logged for auditability, a non-negotiable requirement in regulated pharmacovigilance. Rollout typically starts with a single data source and product before scaling.

Phase 1 establishes the foundational ingestion layer, focusing on real-time API polling of structured call center transcripts and designated patient forums. This initial build delivers immediate value by centralizing fragmented data streams into a single data lake, enabling basic keyword flagging and reducing manual data collection effort by an estimated 40%. The architecture integrates with existing CRM and contact center platforms (e.g., Salesforce Service Cloud, Five9) using secure, compliant connectors, with all outputs routed to a human review queue for validation before any automated actions are taken.

Phase 2 introduces the core agentic orchestration using LangGraph, deploying specialized NLP agents for MedDRA term suggestion and clinical priority scoring against configurable business rules. This phase cuts triage time per signal by over 70% and surfaces high-risk mentions directly into the pharmacovigilance case management system (e.g., Oracle Argus, Veeva Safety). Rigorous controls are implemented, including confidence thresholding for auto-coding and mandatory medical review for all high-priority escalations, ensuring safety and auditability before proceeding to the final phase of full production integration and operational handoff.

Deploying this workflow requires a phased rollout with strict governance gates. Start with a single product and data source, such as call center transcripts, to validate the MedDRA coding agent's precision and the priority-scoring logic against a gold-standard dataset. Implement the orchestrator, likely built on LangGraph, to manage state and enforce approval checkpoints before any signal is promoted to the safety database (e.g., Veeva Safety, Oracle Argus). This initial phase focuses on measuring false-positive rates and tuning agent confidence thresholds under PV physician oversight.

Post-validation, scale the workflow by adding forum sources and languages, each requiring a new governance review. The architecture must log all agent decisions, source data, and reviewer actions to a tamper-evident audit trail, supporting regulatory inspection. Exception handling routes low-confidence signals to a human-in-the-loop queue, while automated QC checks run before database entry. This controlled approach balances automation speed with the mandatory oversight required in pharmacovigilance, turning unstructured patient feedback into auditable, actionable safety intelligence.